BenevolentAI
Applies artificial intelligence to accelerate drug discovery and development.
BAI | AS
Overview
Corporate Details
- ISIN(s):
- LU2355630455
- LEI:
- 2221003P54KEDC3P4Z33
- Country:
- United Kingdom
- Address:
- 4-8 Maple Street, W1T 5HD London
- Website:
- https://www.benevolent.com/
Description
BenevolentAI is a clinical-stage company that specializes in applying artificial intelligence (AI) and machine learning to drug discovery and development. The company utilizes its proprietary technology platform, which is built upon a comprehensive knowledge graph, to analyze vast amounts of complex biomedical information. This platform is designed to generate novel biological insights, identify new therapeutic targets, and accelerate the research and development process for new medicines. By integrating advanced AI with scientific expertise, BenevolentAI aims to decipher complex disease biology and improve the efficiency and success rate of bringing new treatments to patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-03-12 12:12 |
BAI EGM Results APPROVED
|
English | 169.9 KB | ||
| 2025-02-06 07:00 |
Merger-Delisting and Notice of EGM FINAL APPROVED copy
|
English | 95.2 KB | ||
| 2024-12-11 13:17 |
BenevolentAI unveils major strategic overhaul with return to original mission
|
English | 440.5 KB | ||
| 2024-12-11 07:00 |
241211_BenevolentAI Statement_FINAL
|
English | 440.5 KB | ||
| 2024-12-03 13:36 |
Regulatory Announcement - Issue of Equity and TVR (RSU Settlement) 03122024
|
English | 111.3 KB | ||
| 2024-10-17 07:00 |
241017 BenevolentAI_Leadership update_Final
|
English | 384.6 KB | ||
| 2024-09-23 14:15 |
Major Shareholding Notification (LINK) - 13 September 2024 rev
|
English | 494.2 KB | ||
| 2024-09-19 07:00 |
240919_BAI Interims 24 press release_FINAL
|
English | 468.9 KB | ||
| 2024-07-30 12:56 |
PDMR Notification - Dr. Joerg Moeller
|
English | 56.6 KB | ||
| 2024-07-03 07:00 |
BAI_LEADERSHIP TEAM CHANGE_FINAL_03.07.2024
|
English | 140.6 KB | ||
| 2024-05-02 15:30 |
AGM Results 2 May 2024 FINAL
|
English | 129.2 KB | ||
| 2024-05-01 12:37 |
Major Holdings Notification (Annex A) ABG-ODY-BAI LIMITED
|
English | 62.7 KB | ||
| 2024-04-23 07:00 |
Business Update 23 April 24 FINAL
|
English | 166.2 KB | ||
| 2024-04-17 07:00 |
BAI_Publication of the Revised Agenda for the 2024 AGM_FINAL_17.04.24
|
English | 69.7 KB | ||
| 2024-04-15 07:00 |
BAI_PROPOSED CHANGES TO BOARD COMPOSITION _FINAL_15.04.24
|
English | 168.4 KB |
Automate Your Workflow. Get a real-time feed of all BenevolentAI filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BenevolentAI
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BenevolentAI via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
